Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SIXB
Materials
SIXB
Materials
SIXB
-1,41%
1 076,13
-15,38
-1,41%
1 091,511 090,401 090,401 073,69
SIXC
Communications
SIXC
Communications
SIXC
-0,55%
606,74
-3,37
-0,55%
610,11610,11610,29606,17
SIXE
Energy
SIXE
Energy
SIXE
+0,88%
1 248,82
+10,84
+0,88%
1 237,981 237,831 252,411 225,03
SIXI
Industrials
SIXI
Industrials
SIXI
-1,17%
1 724,36
-20,35
-1,17%
1 744,711 740,951 747,291 721,57
SIXM
Financials
SIXM
Financials
SIXM
-0,72%
635,59
-4,59
-0,72%
640,18639,92643,19634,73
SIXR
Staples
SIXR
Staples
SIXR
-0,76%
843,15
-6,43
-0,76%
849,58845,27851,68839,47
SIXRE
Real estate
SIXRE
Real estate
SIXRE
-0,55%
216,29
-1,19
-0,55%
217,48217,48218,16215,51
SIXT
Technology
SIXT
Technology
SIXT
+0,08%
3 263,41
+2,72
+0,08%
3 260,693 273,363 287,813 240,78
SIXU
Utilities
SIXU
Utilities
SIXU
-0,34%
939,24
-3,21
-0,34%
942,45939,39948,80933,98
SIXV
Health care
SIXV
Health care
SIXV
-0,29%
1 462,56
-4,24
-0,29%
1 466,801 464,701 467,191 458,36
SIXY
Discretionary
SIXY
Discretionary
SIXY
-0,71%
2 380,40
-17,10
-0,71%
2 397,502 395,032 412,012 370,64
ABVX:NASDAQ
Abivax SA
117,13 US$
-0,41%
(-0,48) 1D
117,13 US$
0,00% (0,00)
After hours
Closed: 4 მაი, 16:00:01 GMT-4  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ABVX...
Open
118,31 US$
High
119,04 US$
Low
114,85 US$
Mkt. cap
8,20 მლრდ.
Avg. vol.
969,53 ათ.
Volume
654,18 ათ.
52-wk high
148,83 US$
52-wk low
5,59 US$
Shares outstanding
79,29 მლნ.
No. of employees
69
News stories
From sources across the web
Profile
Abivax SA is a clinical stage biotechnology company focused on developing innovative treatments that harness the body’s natural regulatory mechanisms to modulate the immune response in patients with chronic inflammatory diseases. Abivax has a program in clinical development with its lead drug candidate, obefazimod, to treat ulcerative colitis. Another program in Crohn’s disease is also in preparation and other potential inflammatory indications are being evaluated. The company’s headquarters are based in Paris, France with a US office in Waltham, Massachusetts. Abivax’s Research and development work is conducted at its research center based in Montpellier, France. Wikipedia
About Abivax SA
CEOჰარტმუტ ჯეი ერლიხი
Employees69
Founded4 დეკ. 2013
Headquarters-
Sector-
Websiteabivax.com
Previous reportsAll values in EUR
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in EUR
მარ. 2025
ივნ. 2025
სექ. 2025
დეკ. 2025
Revenue
970,00 ათ.
1,05 მლნ.
639,00 ათ.
1,91 მლნ.
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
39,30 მლნ.
38,64 მლნ.
55,42 მლნ.
44,40 მლნ.
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
8,89 მლნ.
8,94 მლნ.
27,34 მლნ.
27,69 მლნ.
Operating expense
48,17 მლნ.
47,54 მლნ.
81,35 მლნ.
73,56 მლნ.
Total operating expenses
48,17 მლნ.
47,54 მლნ.
81,35 მლნ.
73,56 მლნ.
Operating income
-47,20 მლნ.
-46,50 მლნ.
-80,71 მლნ.
-71,65 მლნ.
Other non operating income
431,00 ათ.
2,66 მლნ.
-74,20 მლნ.
-4,96 მლნ.
EBT including unusual items
-52,37 მლნ.
-48,41 მლნ.
-153,36 მლნ.
-76,11 მლნ.
EBT excluding unusual items
-51,32 მლნ.
-48,41 მლნ.
-153,36 მლნ.
-80,84 მლნ.
Income tax expense
-
-
-
5,85 მლნ.
Effective tax rate
-
-
-
-7,68%
Other operating expenses
-24,00 ათ.
-46,00 ათ.
-1,40 მლნ.
1,47 მლნ.
Net income
-52,37 მლნ.
-48,41 მლნ.
-153,36 მლნ.
-81,96 მლნ.
Net profit margin
-5 398,97%
-4 624,07%
-23 999,69%
-4 282,13%
Earnings per share
-
-
-
-
Interest and investment income
859,00 ათ.
190,00 ათ.
3,36 მლნ.
1,19 მლნ.
Interest expense
-4,54 მლნ.
-3,52 მლნ.
-4,21 მლნ.
-15,27 მლნ.
Net interest expenses
-3,68 მლნ.
-3,33 მლნ.
-852,00 ათ.
-14,08 მლნ.
Depreciation and amortization charges
-
-
-
-
EBITDA
-47,12 მლნ.
-46,47 მლნ.
-80,63 მლნ.
-70,76 მლნ.
Gain or loss from assets sale
-
-
-
-
AI content may include mistakes. Learn more

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more